Biotech News Seattle Genetics

Seattle Genetics Stock Jumps after Positive Trial Results with ErbB-2 Inhibitor Tucatinib

Biotech News | 22.10.2019

Seattle Genetics was one of the main winners of this year's ESMO congress. The company's shares...